Ledger.Open graph →
SEC Form D · Amendment · filed January 25, 2023

Reprise Biomedical, Inc

Offering
$15.3M
Sold
$15.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Plymouth, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Howard Root · PLYMOUTH, MNExec · DirectorRonald Eibensteiner · PLYMOUTH, MNDirectorPhil Nalbone · PLYMOUTH, MNDirectorErwin Kelen · PLYMOUTH, MNDirectorCarrie Powers · PLYMOUTH, MNExec · DirectorPhillip Nalbone · PLYMOUTH, MNDirectorDaniel Auerbach · South San Francisco, CADirectorPaul H. Sartori · Charlottesville, VAExec · DirectorPaul Kim · Wilmington, DEDirectorAlex Thompson · Provo, UTExec · DirectorPeter Morrow · San Diego, CADirectorChristopher P. Hill · San Antonio, TXDirectorThomas Pace · Austin, TXExec · DirectorAnne Marie Morley · CHICAGO, ILExec · DirectorStephen Swanson · CHICAGO, ILDirectorZia Rahman · Alpharetta, GADirectorSri Srinivasari · Chicago, ILDirectorWilliam L. Butler, Jr · Cincinnati, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗